Physician profile
John Brown
NPI 1720146509
$2,490.83
in general payments reported to CMS, 2019-2025
18 companies · $807 in 2025
The $807 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $961 · 2020: $241 · 2021: $349 · 2022: $37.74 · 2023: $53.24 · 2024: $42.25 · 2025: $807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716 · Travel and Lodging: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $715.96 |
| Travel and Lodging | $186.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $554.08 | 2024-2025 | Intracept, Wavewriter Alpha Prime 16, Na |
| Lilly USA, LLC | $339.59 | 2019-2021 | |
| Pfizer INC. | $319.01 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $297.38 | 2019-2021 | |
| Nalu Medical, INC. | $186.61 | 2025 | Nalu Neurostimulation System |
| Abbvie INC. | $122.83 | 2021-2023 | Vraylar |
| Spinal Simplicity, LLC | $113.06 | 2021 | |
| Allergan, INC. | $110.37 | 2019-2020 | |
| Amarin Pharma, INC. | $87.73 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.74 | 2019-2020 | |
| Globus Medical, INC. | $72.87 | 2025 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $66.16 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $61.26 | 2019-2025 | Gardasil 9, Capvaxive, Rotateq |
| Si-Bone, INC. | $19.34 | 2024 | |
| Ironwood Pharmaceuticals, INC | $18.71 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $17.03 | 2021 | |
| Glaxosmithkline, LLC. | $14.63 | 2020 | |
| Sanofi Pasteur INC. | $11.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.